Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis

European Journal of Pharmacology

Volumn 554, Issue 1, 2007, Pages 60-68

  Li, Jun ^a   Leschka, Sebastian ^a   Rutschow, Susanne ^a   Schwimmbeck, Peter Lothar ^a   Husmann, Lars ^a   Noutsias, Michel ^a   Westermann, Dirk ^a   Poller, Wolfgang ^a   Zeichhardt, Heinz ^a   Klingel, Karin ^b   Tschope, Carsten ^a   Schultheiss, Heinz Peter ^a   Pauschinger, Matthias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cytokines; IL 4; Matrix metalloproteinases; Myocarditis

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CYTOKINE; FAST BLUE; GELATINASE A; GELATINASE B; INTERLEUKIN 2; MATRIX METALLOPROTEINASE; MESSENGER RNA; RECOMBINANT INTERLEUKIN 4; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CD8+ T LYMPHOCYTE; CHEMICAL ANALYSIS; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DOWN REGULATION; ENTEROVIRUS; ENZYME ACTIVITY; GENOME; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN SITU HYBRIDIZATION; INBRED STRAIN; MACROPHAGE; MALE; MOUSE; MYOCARDITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TH1 CELL; ZYMOGRAPHY;

ANIMALS; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; MYOCARDITIS; MYOCARDIUM; RNA, MESSENGER; VENTRICULAR FUNCTION, LEFT; VIRAL LOAD;

EID: 33751436595     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.024     Document Type: Article

References (39)

1. Chen H., Li D., Saldeen T., and Mehta J.L. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am. J. Physiol.: Heart Circ. Physiol. 284 (2003) H1612-H1617
2. Chizzolini C., Rezzonico R., De Luca C., Burger D., and Dayer J.M. Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. J. Immunol. 164 (2000) 5952-5960
3. Corcoran M.L., Stetler-Stevenson W.G., Brown P.D., and Wahl L.M. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267 (1992) 515-519
4. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J., Angel P., and Heath J.K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6 (1987) 1899-1904
5. Fairweather D., Yusung S., Frisancho S., Barrett M., Gatewood S., Steele R., and Rose N.R. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication. J. Immunol. 170 (2003) 4731-4737
6. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., Davis S.E., Gatewood S.J., Njoku D.B., and Rose N.R. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am. J. Pathol. 165 (2004) 1883-1894
7. Gross A., Ben-Sasson S.Z., and Paul W.E. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J. Immunol. 150 (1993) 2112-2120
8. He C.S., Wilhelm S.M., Pentland A.P., Marmer B.L., Grant G.A., Eisen A.Z., and Goldberg G.I. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2632-2636
9. Huber S.A., and Job L.P. Differences in cytolytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infect. Immun. 39 (1983) 1419-1427
10. Huber S.A., Polgar J., Schultheiss P., and Schwimmbeck P. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J. Virol. 68 (1994) 195-206
11. Ihn H., Yamane K., Asano Y., Kubo M., and Tamaki K. IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J. Immunol. 168 (2002) 1895-1902
12. Inobe J., Slavin A.J., Komagata Y., Chen Y., Liu L., and Weiner H.L. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28 (1998) 2780-2790
13. Kim S.J., Denhez F., Kim K.Y., Holt J.T., Sporn M.B., and Roberts A.B. Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264 (1989) 19373-19378
14. Kishimoto C., Kuribayashi K., Masuda T., Tomioka N., and Kawai C. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation 71 (1985) 1247-1254
15. Klingel K., Hohenadl C., Canu A., Albrecht M., Seemann M., Mall G., and Kandolf R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 314-318
16. Lacraz S., Nicod L., Galve-de Rochemonteix B., Baumberger C., Dayer J.M., and Welgus H.G. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90 (1992) 382-388
17. Lerner C.G., Horton M.R., Schwartz R.H., and Powell J.D. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells. J. Immunol. 164 (2000) 3996-4002
18. Li J., Schwimmbeck P.L., Tschope C., Leschka S., Husmann L., Rutschow S., Reichenbach F., Noutsias M., Kobalz U., Poller W., Spillmann F., Zeichhardt H., Schultheiss H.P., and Pauschinger M. Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc. Res. 56 (2002) 235-247
19. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
20. Loetscher P., Seitz M., Baggiolini M., and Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184 (1996) 569-577
21. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357
22. Murphy G., Allan J.A., Willenbrock F., Cockett M.I., O'Connell J.P., and Docherty A.J. The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267 (1992) 9612-9618
23. Murphy E., Shibuya K., Hosken N., Openshaw P., Maino V., Davis K., Murphy K., and O'Garra A. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183 (1996) 901-913
24. Murray D.R., and Freeman G.L. Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs. Circ. Res. 78 (1996) 154-160
25. Natuk R.J., and Welsh R.M. Chemotactic effect of human recombinant interleukin 2 on mouse activated large granular lymphocytes. J. Immunol. 139 (1987) 2737-2743
26. Nishio R., Matsumori A., Shioi T., Ishida H., and Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 100 (1999) 1102-1108
27. Ogata Y., Enghild J.J., and Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267 (1992) 3581-3584
28. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., and Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72 (1995) 311-322
29. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L., Kuhl U., and Schultheiss H.P. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99 (1999) 2750-2756
30. Samoszuk M., and Yang Q.B. Effects of interleukin 4 on production of IgE monoclonal antibodies directed against glucose oxidase. Hybridoma 13 (1994) 437-439
31. Saren P., Welgus H.G., and Kovanen P.T. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157 (1996) 4159-4165
32. Shioi T., Matsumori A., and Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 94 (1996) 2930-2937
33. Tanaka T., Hu-Li J., Seder R.A., Fazekas de St Groth B., and Paul W.E. Interleukin 4 suppresses interleukin 2 and interferon gamma production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5914-5918
34. Taniguchi T., and Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 73 (1993) 5-8
35. Thomas C.V., Coker M.L., Zellner J.L., Handy J.R., Crumbley III A.J., and Spinale F.G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 (1998) 1708-1715
36. Van Obberghen-Schilling E., Roche N.S., Flanders K.C., Sporn M.B., and Roberts A.B. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263 (1988) 7741-7746
37. Vella A.T., Dow S., Potter T.A., Kappler J., and Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3810-3815
38. Yoshimoto K., Swain S.L., and Bradley L.M. Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rIL-4 in vivo. J. Immunol. 156 (1996) 3267-3274
39. Zhang Y., McCluskey K., Fujii K., and Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161 (1998) 3071-3076